|
CMAS expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.36029999989285E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.399000E-04 |
| Normal-vs-Stage2 |
5.085500E-02 |
| Normal-vs-Stage3 |
3.634100E-04 |
| Normal-vs-Stage4 |
1.694030E-02 |
| Stage1-vs-Stage2 |
7.036800E-01 |
| Stage1-vs-Stage3 |
5.264800E-03 |
| Stage1-vs-Stage4 |
1.175570E-01 |
| Stage2-vs-Stage3 |
1.308990E-01 |
| Stage2-vs-Stage4 |
2.887600E-01 |
| Stage3-vs-Stage4 |
7.922800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63009999998298E-06 |
| Normal-vs-AfricanAmerican |
7.558700E-04 |
| Normal-vs-Asian |
1.004800E-01 |
| Caucasian-vs-AfricanAmerican |
7.862800E-01 |
| Caucasian-vs-Asian |
2.464200E-01 |
| AfricanAmerican-vs-Asian |
3.287000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.68353999999704E-05 |
| Normal-vs-Female |
4.69049999995974E-06 |
| Male-vs-Female |
8.862300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.054430E-02 |
| Normal-vs-Extreme_Weight |
9.045200E-04 |
| Normal-vs-Obese |
1.759540E-03 |
| Normal-vs-Extreme_Obese |
6.406800E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.294400E-01 |
| Normal_Weight-vs-Obese |
8.594000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.235000E-01 |
| Extreme_Weight-vs-Obese |
9.162800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.032800E-01 |
| Obese-vs-Extreme_Obese |
2.843200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.237020E-04 |
| Normal-vs-Age(41-60Yrs) |
2.09029999999055E-05 |
| Normal-vs-Age(61-80Yrs) |
2.587400E-04 |
| Normal-vs-Age(81-100Yrs) |
1.139780E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.383840E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.899800E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.604100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.540600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.727400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.219400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.03230000009825E-07 |
| Normal-VS-Type2 PRCC |
7.762200E-03 |
| Normal-VS-KIRP CIMP |
1.641020E-03 |
| Normal-VS-Unclassified PRCC |
6.864800E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.576400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.495820E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.481800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.277700E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
4.189000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.485700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.855820E-02 |
| Normal-vs-N1 |
2.33729999999932E-05 |
| Normal-vs-N2 |
1.578020E-01 |
| N0-vs-N1 |
1.129530E-02 |
| N0-vs-N2 |
3.354400E-01 |
| N1-vs-N2 |
8.003800E-01 |
|
|
